Alexander Pickett
Managing Director @ Juvenescence
Douglas, Isle of Man
Alexander Pickett is a Principal at Mediqventures, a multi-family investment partnership and merchant bank. While at Mediqventures, he supported existing investments in Portage Biotech Inc. and Biohaven (NYSE:BHVN) and helped found SalvaRx Limited, a cancer-immunotherapy focused investment company. Prior to joining Mediqventures, he was anassociate at Flatley Venture Capital, a cystic fibrosis focused investment arm of a family office, where he was responsible for investment analysis and scientific due diligence. While there, he also supported Flatley Discovery Lab's business development efforts. Alexander co-founded Real Life Sciences, a start-up focused on using software-based patient-engagement solutions in order to improve patient recruitment to clinical trials.Prior to joining Flatley Venture Capital, Alexander graduated from Harvard College with an A.B. in Molecular and Cellular Biology, where he was a Microbial Studies Initiative Undergraduate Fellow and an International Genetically Engineered Machines Competition Team Member.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Morphoceuticals
|
Morphoceuticals is a biotechnology platform establishing a basis for limb regeneration and the discovery of regenerative interventions. It focuses on the understanding of the biophysical mechanisms that implement decision-making during complex pattern regulation and utilizes bioelectric dynamics to change developmental patterning and spurregeneration in organisms that do not regenerate tissues or organs. It helps medical researchers to treat complicated health states through limb regeneration, improving amputation stump health, promoting organ regeneration, and the treatment of channelopathies. | $8M / Seed / Jan 23, 2023 |
Co-Investors
About Juvenescence
Juvenescence Limited is a British Virgin Islands-based holding company that invests in human aging and longevity. Juvenescence has raised $111M to build an ecosystem and pipeline of assets targeting aging, age-related disease, and regeneration. Juvenescence believes that recent scientific and medical advances will enable the development oftherapeutics that meaningfully extend human healthspan and eventually lifespan. A meaningful increase in lifespan in the already aging world will have profound implications on all sectors of society, and in particular healthcare, education, insurance, and leisure.The company creates and partners with new companies with longevity-related therapeutics, by in-licensing compounds from academia and industry, or forming joint ventures with the foremost longevity scientists and leading research institutions. Their work is based on a novel scientific understanding of the underlying biological causes of aging, to create evidence-based therapeutics that can treat diseases of aging.Juvenescence's goal is to extend both lifespan and healthspan, by developing therapeutics that slow aging and promote juvenescence.
Juvenescence Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Anthony Chow
VP IR
|
|||
Jim Mellon
Chairman
|
|||
|
Alexander Pickett
Managing Director
|
|||
Casey Swerner
Vice President
|
|||
Declan Doogan
Chief Medical Officer
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
When did Alexander Pickett last invest?
The most recent investment recorded for Alexander Pickett closed in Jan 2023. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
